S-100B protein as a serum marker of secondary neurological complications in neurocritical care patients.

@article{Raabe2004S100BPA,
  title={S-100B protein as a serum marker of secondary neurological complications in neurocritical care patients.},
  author={Andreas Raabe and Olaf Kopetsch and Alina Woszczyk and Josef Lang and R{\"u}ediger Gerlach and Michael Zimmermann and V. Seifert},
  journal={Neurological research},
  year={2004},
  volume={26 4},
  pages={440-5}
}
There is growing evidence that S-100B protein measured by a simple blood test can be used as a novel biochemical marker of brain cell damage. The objective of our study was to investigate the potential of S-100B measurements to diagnose an acute neurological complication in the analgo-sedated and intubated intensive care patient and the impact on patient management. Serum S-100B levels were serially investigated in 246 neurocritical care patients. Venous blood samples for S-100B determination… CONTINUE READING